These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17078868)

  • 41. NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.
    Saponaro C; Vagheggini A; Scarpi E; Centonze M; Catacchio I; Popescu O; Pastena MI; Giotta F; Silvestris N; Mangia A
    J Exp Clin Cancer Res; 2018 May; 37(1):96. PubMed ID: 29716631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
    Gu Y; Yu H; Hao C; Martin TA; Hargest R; He J; Cheng S; Jiang WG
    Oncotarget; 2017 Jan; 8(5):7753-7765. PubMed ID: 27999191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism.
    Greco MR; Bon E; Rubino R; Guerra L; Bernabe-Garcia M; Cannone S; Cayuela ML; Ciaccia L; Marionneau-Lambot S; Oullier T; Fromont G; Guibon R; Roger S; Reshkin SJ; Cardone RA
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):26-37. PubMed ID: 30326259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation.
    Oh YS; Heo K; Kim EK; Jang JH; Bae SS; Park JB; Kim YH; Song M; Kim SR; Ryu SH; Kim IH; Suh PG
    Exp Mol Med; 2017 Jul; 49(7):e351. PubMed ID: 28684865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell cycle machinery: links with genesis and treatment of breast cancer.
    Butt AJ; Caldon CE; McNeil CM; Swarbrick A; Musgrove EA; Sutherland RL
    Adv Exp Med Biol; 2008; 630():189-205. PubMed ID: 18637492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
    Leiphrakpam PD; Lazenby AJ; Chowdhury S; Smith LM; Mathiesen M; Brattain MG; Wang J; Black JD; Are C
    J Surg Oncol; 2020 Mar; 121(3):547-560. PubMed ID: 31867736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The PDZ Protein Na+/H+ Exchanger Regulatory Factor-1 (NHERF1) Regulates Planar Cell Polarity and Motile Cilia Organization.
    Treat AC; Wheeler DS; Stolz DB; Tsang M; Friedman PA; Romero G
    PLoS One; 2016; 11(4):e0153144. PubMed ID: 27055101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Down-regulation of the Tumor Suppressor CYLD Enhances the Transformed Phenotype of Human Breast Cancer Cells.
    Orfanidou T; Xanthopoulos K; Dafou D; Pseftogas A; Hadweh P; Psyllaki C; Hatzivassiliou E; Mosialos G
    Anticancer Res; 2017 Jul; 37(7):3493-3503. PubMed ID: 28668838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NHERF1/EBP50 in Breast Cancer: Clinical Perspectives.
    Bellizzi A; Malfettone A; Cardone RA; Mangia A
    Breast Care (Basel); 2010; 5(2):86-90. PubMed ID: 21048827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers.
    Zudaire E; Cuesta N; Murty V; Woodson K; Adams L; Gonzalez N; Martínez A; Narayan G; Kirsch I; Franklin W; Hirsch F; Birrer M; Cuttitta F
    J Clin Invest; 2008 Feb; 118(2):640-50. PubMed ID: 18172554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients.
    Mangia A; Scarpi E; Partipilo G; Schirosi L; Opinto G; Giotta F; Simone G
    Oncotarget; 2017 Sep; 8(39):65730-65742. PubMed ID: 29029467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma.
    Aksionau A; Silva RA; Hartman B; Flowers A
    Transl Androl Urol; 2023 Aug; 12(8):1283-1295. PubMed ID: 37680228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Na
    Zhang X; Liu J; Li Z
    Oncol Lett; 2018 May; 15(5):7725-7729. PubMed ID: 29725468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic Proteogenomic Approach To Exploring a Novel Function for NHERF1 in Human Reproductive Disorder: Lessons for Exploring Missing Proteins.
    Na K; Shin H; Cho JY; Jung SH; Lim J; Lim JS; Kim EA; Kim HS; Kang AR; Kim JH; Shin JM; Jeong SK; Kim CY; Park JY; Chung HM; Omenn GS; Hancock WS; Paik YK
    J Proteome Res; 2017 Dec; 16(12):4455-4467. PubMed ID: 28960081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of functional proteomic analyses of human breast cancer cell lines T47D and MCF7.
    Aka JA; Lin SX
    PLoS One; 2012; 7(2):e31532. PubMed ID: 22384035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumour-promoting activity of altered WWP1 expression in breast cancer and its utility as a prognostic indicator.
    Nguyen Huu NS; Ryder WD; Zeps N; Flasza M; Chiu M; Hanby AM; Poulsom R; Clarke RB; Baron M
    J Pathol; 2008 Sep; 216(1):93-102. PubMed ID: 18604872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor suppressor genes and their roles in breast cancer.
    Cox LA; Chen G; Lee EY
    Breast Cancer Res Treat; 1994; 32(1):19-38. PubMed ID: 7819583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer.
    Simigdala N; Chalari A; Sklirou AD; Chavdoula E; Papafotiou G; Melissa P; Kafalidou A; Paschalidis N; Pateras IS; Athanasiadis E; Konstantopoulos D; Trougakos IP; Klinakis A
    Cell Mol Life Sci; 2023 Mar; 80(4):100. PubMed ID: 36933062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NHERF1/EBP50 as a Target for Modulation of MRP Function in HepG2 Cells.
    Kawase A; Hirosoko M; Sugihara Y; Koyama Y; Fukae A; Shimada H; Iwaki M
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33800412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spinophilin: a new tumor suppressor at 17q21.
    Carnero A
    Curr Mol Med; 2012 Jun; 12(5):528-35. PubMed ID: 22515982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.